90 participants
A Randomized, Blinded, Placebo-controlled Phase I Clinical Trial Evaluating the Safety and Preliminary Immunogenicity of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-11-24
- Start Date:
- 2019-09-07
- Completion:
- 2021-10-13
Conditions
- HPV Infection
- HPV-Related Cervical Carcinoma
Interventions
- BIOLOGICAL
No Results Yet